SCHEMBL9534239

SCHEMBL9534239

Oc1nc2cc(Cl)c3nc(C(F)(F)F)[nH]c3c2nc1O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 2/20 0.38
CSNK2A2 P19784 1/20 0.38
CSNK2B P67870 1/20 0.38
HSD17B10 Q99714 2/20 0.35
HTT P42858 1/20 0.35
MAPT P10636 4/20 0.34
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34
AR P10275 3/20 0.33
TRPV1 Q8NER1 1/20 0.32
KDM4E B2RXH2 3/20 0.32
HPGD P15428 3/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
USP2 O75604 1/20 0.32
TSHR P16473 1/20 0.32
POLB P06746 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
PARP1 P09874 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20636784 0.71 KIF20B (0.48) HTTMAPTKDM4EPOLBALDH1A1
SCHEMBL9868847 0.71 CSNK2A1 (0.47) CSNK2A1CSNK2A2CSNK2BHSD17B10HTT
SCHEMBL7558600 0.70 CSNK2A1 (0.40) CSNK2A1CSNK2A2CSNK2BHSD17B10HTT
SCHEMBL9534185 0.69 CSNK2A1 (0.36) CSNK2A1CSNK2A2CSNK2BMAPTPOLB
SCHEMBL9865741 0.68 HPGD (0.42) CSNK2A1CSNK2A2CSNK2BHSD17B10HTT
SCHEMBL29362247 0.66 CSNK2A1 (0.36) CSNK2A1CSNK2A2CSNK2BHSD17B10HTT
SCHEMBL29138004 0.66 CSNK2A1 (0.36) CSNK2A1CSNK2A2CSNK2BHSD17B10HTT
SCHEMBL12843366 0.65 CSNK2A1 (0.39) CSNK2A1CSNK2A2CSNK2BHSD17B10HTT
SCHEMBL8183601 0.65 HTT (0.56) CSNK2A1CSNK2A2CSNK2BHSD17B10HTT
SCHEMBL20092266 0.65 HSD17B10 (0.40) CSNK2A1CSNK2A2CSNK2BHSD17B10HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0348872-B1 FUSED DIHYDROXYQUINOXALINES AND THEIR USE AS GLUTAMATE ANTAGONISTS NOVO NORDISK A/S (DK) 1993-09-29 EP disclosed
US-5109001-A Treating hyperactivity of excitatory neurotransmitters NOVO NORDISK A/S (DK) 1992-04-28 US disclosed
US-5079250-A TRICYCLIC HETEROCYCLIC DIOLS AND THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1992-01-07 US disclosed
US-5075306-A Nervous system, psychological disorders NOVO NORDISK A/S (DK) 1991-12-24 US disclosed
US-5057516-A Nervous system disorders NOVO NORDISK A/S (DK) 1991-10-15 US disclosed
US-4977155-A Nervous system disorders A/S FERROSAN (DK) 1990-12-11 US disclosed
EP-0348872-A1 Fused dihydroxyquinoxalines and their use as glutamate antagonists NOVO NORDISK A/S (DK) 1990-01-03 EP disclosed